Assenagon Asset Management
SYNH

Assenagon Asset Management’s Syneos Health, Inc. Class A Common Stock SYNH Stock Holding History

Assenagon Asset Management’s Portfolio SYNH Stock Details SYNH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-1,531,569
Closed -$54.6M – 1502
2023
Q1 		$54.6M Buy
1,531,569
+475,419
+45% +$17.3M 0.19% 98
2022
Q4 		$38.7M Buy
1,056,150
+558,694
+112% +$22.1M 0.14% 145
2022
Q3 		$23.5M Buy
497,456
+417,559
+523% +$27M 0.09% 220
2022
Q2 		$5.73M Sell
79,897
-49,795
-38% -$3.64M 0.02% 506
2022
Q1 		$10.5M Buy
129,692
+111,744
+623% +$9.45M 0.03% 360
2021
Q4 		$1.84M Sell
17,948
-542,181
-97% -$52.1M 0.01% 844
2021
Q3 		$49M Buy
560,129
+303,464
+118% +$27.5M 0.16% 117
2021
Q2 		$23M Buy
256,665
+95,911
+60% +$8.1M 0.08% 209
2021
Q1 		$12.2M Sell
160,754
-19,844
-11% -$1.5M 0.05% 303
2020
Q4 		$12.3M Buy
+180,598
New +$11.3M 0.05% 219
2020
Q2 		– Sell
-11,918
Closed -$470K – 1272
2020
Q1 		$470K Buy
+11,918
New +$697K ﹤0.01% 651

Other funds holding SYNH

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
UOC
UBS O'Connor Chicago, Illinois $3.38B AUM 63.08% 1-Year Est. Return
EIM
Elliott Investment Management West Palm Beach, Florida $20.1B AUM 60.76% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
GCL
Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

Assenagon Asset Management's SYNH Position: Q2 2023 in Review

Assenagon Asset Management sold out of Syneos Health, Inc. Class A Common Stock (SYNH) in Q2 2023, closing a stake of 1,531,569 shares — an estimated $54.6M sold.

Assenagon Asset Management first reported a position in SYNH in Q1 2020 and held it in 11 quarters. The position peaked at $54.6M in Q1 2023. 317 funds tracked by Wall St. Rank hold SYNH as of Q2 2023.

  • Assenagon Asset Management reported no remaining Syneos Health, Inc. Class A Common Stock position as of Q2 2023 after selling out during the quarter.
  • Assenagon Asset Management sold 1,531,569 Syneos Health, Inc. Class A Common Stock shares in Q2 2023, an estimated $54.6M.
  • Assenagon Asset Management first reported a position in Syneos Health, Inc. Class A Common Stock in Q1 2020 and held it in 11 quarters.
  • Assenagon Asset Management's Syneos Health, Inc. Class A Common Stock position peaked at $54.6M in Q1 2023.
  • 317 funds tracked by Wall St. Rank held Syneos Health, Inc. Class A Common Stock as of Q2 2023.

Based on Assenagon Asset Management's 13F filing for Q2 2023, filed 25 Jul 2023.